Výsledky vyhledávání - "Sumedha Mukhi"

Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids

Autor: Vedula Sasibhushan, Sastry Lakshminarayana Jatavallabhula, Deepika Kumari, Sonu Kumar Gupta, Parul Kamboj, Dinesh Mahajan, Sumedha Mukhi, Rajiva Kumar Rai, Soumalya Sarkar, Ajay Kumar, Vipin Sharma, Madhu Dikshit, Yashwant Kumar

Publikováno v: Biomedicine & Pharmacotherapy, Vol 144, Iss, Pp 112357-(2021)

Higher global prevalence of non-alcoholic fatty liver disease (NAFLD) is associated with obesity, steatosis, and insulin resistance (IR), and often progresses to steatohepatitis (NASH). Even after more than twenty years of research, there is still no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f480661809b9937bc949787ed56477
https://doi.org/10.1016/j.biopha.2021.112357

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání